Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07455084

A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults

A Phase 1 Trial to Assess the Mass Balance and Pharmacokinetics of a Single Oral Administration of 14C-SEP-380135 in Healthy Male Adults

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP-380135 and its metabolites following a single oral dose.

Conditions

Interventions

TypeNameDescription
DRUG14C-SEP-380135Oral Capsule

Timeline

Start date
2026-03-20
Primary completion
2026-04-10
Completion
2026-05-03
First posted
2026-03-06
Last updated
2026-03-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07455084. Inclusion in this directory is not an endorsement.